XM does not provide services to residents of the United States of America.

Indian shares track rebound in Asian peers, set to open higher



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares track rebound in Asian peers, set to open higher</title></head><body>

BENGALURU, April 4 (Reuters) -Indian shares are set to open higher on Thursday, as markets track a rebound in Asian peers, supported by sustained retail inflows ahead of the Reserve Bank of India's monetary policy decision later this week.

The Gift Nifty GIFc1 was trading at 22,601.50, as of 0809 a.m. IST, indicating that the blue-chip NSE Nifty 50 index .NSEI will open above Wednesday's close of 22,434.65.

Asian markets opened higher, with the MSCI Asia ex-Japan index .MIAPJ0000PUS adding 0.4% after dropping about 1% in the previous session.

Most Wall Street stock indexes gained overnight as U.S. data showed slowdown in the country's services industry growth, signalling easing inflation. MKTS/GLOB

Indian shares closed flat on Wednesday, outperforming other Asian peers.

Foreign portfolio investors sold 22.14 billion rupees ($265 million) of shares on a net basis, while domestic institutional investors purchased shares worth 11.02 billion rupees, according to provisional data from the National Stock Exchange.

Domestic investors have remained net buyers of Indian shares for 11 consecutive sessions, cushioning outflows from FPIs over the period.

"The market's short-term trajectory will hinge on the outcome of the earnings season, starting next week, with success potentially driving the Nifty 50 to fresh highs, while disappointing results could lead to a period of further consolidation or correction," said Sonam Srivastava, founder and fund manager at Wright Research, PMS.

The RBI is expected to hold rates steady in its monetary policy decision on Friday, according to a Reuters poll of economists.

The markets keenly await the central bank's commentary on inflation and growth to assess future rate outlook, analysts said.

STOCKS TO WATCH:


** Axis Bank AXBK.NS: Competition Commission of India approved proposed infusion of 16.12 billion rupees by the company in Max Life Insurance.

** Avenue Supermarts AVEU.NS: Standalone revenue from operations for March quarter rose 19.9% year-on-year, company said in a business update.

** KEC International KECL.NS: Company got orders worth 8.16 billion rupees. Total order intake for fiscal year 2024 stood at 181.02 billion rupees.

** RBL Bank RATB.NS: Lender said gross advances for March quarter rose 19% year-on-year, while total deposits jumped 22%.


($1 = 83.4830 Indian rupees)



Reporting by Bharath Rajeswaran and Kashish Tandon in Bengaluru; Editing by Sherry Jacob-Phillips

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.